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Urolithiasis is a complex process characterized by supersaturation and retention of salts within the kidney and also a 
debilitating problem worldwide. Here, we have investigated antiurolithiatic effect of trans-cinnamic acid (t-CA) against 
ethylene glycol (EG) induced urolithiasis in rats. Urolithiasis was induced in Wistar albino rats using 0.75% v/v EG in 
drinking water for 28 days. t-CA was administered @200 and 400 mg/kg along with EG for 28 days. Biochemical, urine and 
histopathological analysis were performed to observe the calcium oxalate (CaC2O4) deposits and renal tissue damage. The 
EG group showed significant rise in urine oxalate, calcium, phosphate, and renal tissues oxalates, as compared to normal 
group. Serum creatinine and uric acid levels were also increased significantly in EG-treated group. Histopathological studies 
showed marked renal tissue damage and the presence of CaC2O4 crystals. Further, treatment of t-CA significantly 
ameliorated oxalate, calcium, magnesium, phosphate (urine) and creatinine, uric acid (serum) in EG-induced urolithiasis 
after 28 days. Moreover, t-CA-treated groups showed reversal of renal tissue damage and reduced level of CaC2O4. 
Interestingly, t-CA @400 mg/kg, was more effective in preventing the urolithiasis and regeneration of renal tissues in rats. 
Keywords: Antioxidant, Calcium oxalate, Diuretic, Kidney stone, Nephrolithiasis, Urinary oxalate, Uric acid, Urolithiasis 
Urolithiasis, also known as kidney or renal stone, is a 
multi-factorial disorder and highly prevalent clinical 
problem that accounts for 12% of the human 
population worldwide at some stage in their lifetime. 
Generally, it happens both in men and women, but the 
risk is high in men than women within the age of 20-
49 years. In both developed and developing countries, 
the prevalence of urolithiasis has been increased in 
the past decades
1
. It has been estimated that the 
overall probability of forming stones differ in various 
parts of the world and is estimated at 1-5% in Asia,  
5-9% in Europe, 13% in North America and the 
recurrence rate of renal stones is about 75% in 20 
years span
2
. Approximately, 12% of the Indian 
population is anticipated to have urinary stones and 





There are several options available in the 
management of ureteral stones. Treatment selection 
depends on stone size, location and composition, 
equipment available, physician skill, patient health 
and preference and costs. The surgical operation, 
lithotripsy and local calculus disruption using high-
power laser are widely used to remove the calculi
3,4
. 
However, these techniques are highly costly and  
with these procedures, recurrence is quite common. 
Moreover, surgical interventions may cause 
undesirable side effects such as tubular necrosis, 
hypertension, hemorrhage and subsequent fibrosis of 





The animal models have played an important role 
in basic, etiological studies of stone diseases and the 
identification of herbal medication and other effective 
substances. CaC2O4 urolithiasis models have 
commonly been used to investigate the influence of 
urolithiasis on experimental rats
7,8
. In recent years, 
interest is resurgent for the development and 
utilization of herbal drugs and traditional medicines 
for the benefit of the world population in terms of 
cost-effectiveness and low side effect of these drugs. 
The plant products are reported to be effective in 
decreasing the recurrence rate of renal calculi with no 
side effects. Since ancient times, herbal preparations 
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t-CA is an organic acid occurring naturally in 
plants that has low toxicity and a broad spectrum of 
biological activities. t-CA derivatives, both isolated 
from plant materials and synthesized, showed diverse 
pharmacological activities such as antidiabetic, 
hepatoprotective, antibacterial, anti-inflammatory, 
antiviral and antifungal activity
13








 activities. Additionally, it is well 
documented that the plants which are a rich source of 
t-CA such as Daucus carota L., Bergenia ligulate, 
Nigella sativa, Cynodon dactylon, Rotula aquatica 
and Raphanus sativus have been proven to exhibit 
promising effects in the management of kidney 
stones
16,17
. However, so far no scientific study has 
been reported concerning the antiurolithiatic activity 
of the t-CA. Hence, in the present study, we 
investigated the protective effect of the t-CA against 
EG-induced urolithiasis and its possible underlying 
mechanisms in experimental rats. 
 
Materials and Methods  
 
Chemicals and apparatus 
TBA was purchased from Sigma-Aldrich Co., St. 
Louis, MO, USA. EG and t-CA were purchased from 
Molychem, Mumbai, India. Cystone tablets were 
purchased from Himalaya Drug Company, India. 
Calcium, uric acid, magnesium and creatinine kit 
were purchased from Anamol Diagnostics Ltd, 
Palghar, India. All other chemicals and reagents used 
were of analytical grade and procured from approved 
chemical suppliers. Equipment such as the metabolic 
cages (Tecnip-last, Italy), auto-analyzer (Merck, 
Mumbai, India), centrifuge and homogenizer (Remi 
Industries, Mumbai, India), UV-spectrometer 
(Shimadzu Scientific Instruments, UV-1800, Mumbai, 
India) were used for analysis in the present study. 
 
Animals 
Male Wistar albino rats (150-300 g; eight weeks) 
were used for the present study. The animals were 
housed five rats per cage under well-controlled 
conditions of temperature (25±1°C), humidity 
(55±5%) and 12 h light-dark cycle (lights on 07:00-
19:00 h) in the central animal facility of Department 
of Pharmaceutical Sciences, Saurashtra University, 
Rajkot, Gujarat, India. Animals had free access to 
standard rat chow (Amrut, Pranav Agro Ind. Ltd., 
Vadodara, India) and water ad libitum. All the 
experimental protocols were approved (Protocol 
approval no IAEC/DPS/SU/1231) by the Institutional 
Animal Ethics Committee (IAEC), Department of 
Pharmaceutical Science, Saurashtra University, 
Rajkot, Gujarat, India. The experimental procedures 
were performed as per the guidelines laid by the 
Committee for the Purpose of Control and 
Supervision of Experiments on Animals (CPCSEA), 
Animal Welfare Division, Ministry of Environment 
Forest and Climate Change, Government of India, 
New Delhi. Six rats per cage were allowed to 




Fig. 1 depicts a schematic representation of the 
experimental design and treatment timeline. Briefly, 
EG-induced urolithiasis model
12,18
 was employed for 
the present study. Forty-two animals were randomly 
divided into seven groups (n = 6). The treatment 
groups were as follows: Group I (Vehicle control) 
received 1% CMC in drinking water for 28 days. 
Group II (Lithiatic control) received 0.75% v/v EG in 
drinking water for 28 days. Group III (Cystone) 
received cystone (750 mg/kg) from day 1 to 28. 
Groups IV and V (t-CA preventive) received t-CA at 
the doses of 200 and 400 mg/kg, respectively from 
day 1 to 28. Groups VI and VII (t-CA curative) 
received t-CA at doses of 200 and 400 mg/kg, 
respectively from day 15 to 28 days of calculi 
induction. Treatment groups III-VII received calculi 
inducing treatment for 28 days. All the treatment 
drugs and calculi inducing agent were suspended in 




Collection and analysis of urine 
Animals were kept in individual metabolic cages 




Fig. 1  —Experimental design for urolithiasis study 
 






 day of calculi induction treatment. The 
volume and calcium content of urine were estimated. 
Calcium in urine was estimated using calcium 
diagnostic kit in a semi-autoanalyzer. Urine samples 





, and uric acid
22
. Urine crystals were 





The blood was collected from the retro-orbital sinus 
plexus under the anaesthetic condition and serum was 
separated by centrifugation at 10000×g for 10 min and 
analysed for creatinine and uric acid. The creatinine 
and uric acid diagnostic kits were used to estimate 
serum creatinine and uric acid levels, respectively. 
 
Preparation and analysis of tissue homogenate 
Animals were sacrificed under deep anaesthesia 
and both kidneys were immediately removed. 
Subsequently, the kidneys were washed in cooled 
saline (0.9%), kept on ice and blotted on filter paper 
to remove excess saline. Immediately, the left kidney 
was finely minced and 20% homogenate was prepared 
in tris-HCl buffer (0.02 mol/L, pH 7.4). Kidney 
homogenate was used for assaying tissue calcium, 
oxalate
23
, and LPO activity
11
. Calcium in tissue 






To confirm the incidences of lithiasis and its 
healing, isolated kidneys were subjected to 
histological study. After removal, the right kidney 
was cleaned off extraneous tissues and rinsed in ice-
cold physiological saline and fixed in 10% v/v neutral 
buffered formalin, processed in a series of graded 
alcohol and xylene, embedded in paraffin wax, 
sectioned at 5 μM and stained with hematoxylin and 
eosin (H & E dye) for histological evaluation. The 
slides were examined under microscope (DM3000, 
Lieca, Germany) for the evaluation of kidney 




Microscopy of urinary crystal 
A drop of urine sample obtained was spread on a glass 
slide and visualized under polarized light using Leica 





The results were expressed as mean ± standard 
error mean (SEM). The statistical significance was 
assessed using a one-way analysis of variance 
(ANOVA) followed by Dunnett’s comparison test and 
P <0.05 was considered as statistically significant. 
Results 
 
Effect of t-CA on urinary output 
The urinary output of the vehicle-treated group was 
found to be 7.53±0.53 mL/day/rat on the 28
th 
day, 
which was significantly (P <0.001) decreased in the 
EG-treated group. t-CA (200 and 400 mg/kg, p.o.) 
treated groups significantly heightened (P <0.001) 
urine output as compared to the EG-treated group. 
Cystone (750 mg/kg) produced similar effects (Fig. 2). 
 
Effect of t-CA on urinary oxalate, phosphate and uric acid 
As shown in Fig. 3 (A-C), treatment of 0.75% v/v 
EG in drinking water to male rats for 28 days 
increased levels of oxalate, phosphate and uric acid 
concentration in the urine of lithiatic rats (Gr. II) 
showing hypercalciuria, hyperphosphaturia and 
hyperoxaluria, respectively, as compared to normal 
group. In contrast to these results, the treatment t-CA 
in preventive (Grs IV and V) and curative (Grs VI and 
VII) groups at the doses of 200 and 400 mg/kg, 
significantly (P <0.001) reduced the levels of oxalate, 
phosphate and uric acid in urine. A similar effect was 
observed in the rats treated with cystone (750 mg/kg). 
 
Effect of t-CA on urinary calcium and magnesium 
The results of different treatments on urinary calcium 
and magnesium levels are presented in Fig. 3 (D and E). 
As compared to control group, the excretion of 
calcium was significantly (P <0.001) increased whereas, 
excretion of magnesium was decreased gradually in 
lithiatic rats. Supplementation with t-CA (200 and 




Fig. 2 — Effect of t-CA on urine output. [Values are expressed as 
mean ± SEM, N = 6, ANOVA followed by Dunnett’s multiple 
comparison test, **P <0.01 and ***P <0.001. Comparisons are 
made against lithiatic control group] 
 




restored it to near-normal values. The effect was well-
comparable to cystone (750 mg/kg). 
 
Effect of t-CA on urinary pH 
Urine pH levels in different treatment groups 
shown in Fig. 3F. Urine pH analysis of EG-treated rats 
showed a significant (P <0.01) decline in urine pH as 
compared to normal rats whereas, treatment with 
cystone (750 mg/kg) and t-CA (200 and 400 mg/kg) 
restored the pH values to normal. 
 
Effect of t-CA on serum and kidney homogenate analysis 
The renal function was assessed by measuring 
serum creatinine and uric acid in normal, lithiatic 
control and treated rats and the results are depicted in 
Fig. 4 A & B. The serum creatinine and uric acid 
levels were significantly (P <0.001) elevated in 
lithiatic group because of obstruction of the urinary 
system due to renal papillary hypertrophy and crystal 




Fig. 3 — Effect of t-CA on (A) Oxalate; (B) Phosphate; (C) Uric acid; (D) Calcium; (E) Magnesium; and (F) pH from the urine samples. 
[Values are expressed as mean ± SEM, n = 6, ANOVA followed by Dunnett ’s multiple comparison test, *P <0.05, **P <0.01,  
***P <0.001. Comparisons are made against lithiatic control group] 
 




which results in the accumulation of uric acid in the 
blood (Gr. II) whereas, treatment with t-CA (200 and 
400 mg/kg) significantly (P <0.001) reduced the 
levels of these markers. Interestingly, the effect of  
t-CA treatment (400 mg/kg) was well-comparable to 
the effect of standard drug cystone (750 mg/kg) on 
serum creatinine levels. 
 
Furthermore, Fig. 4 (C-E) depicts the deposition of 
oxalate, a crystalline component, and % LPO in the 
renal tissue. Lithiatic group (Gr.  II) showed increase 
incidences of deposition of the CaC2O4 crystals 
whereas, treatment with t-CA (200 and 400 mg/kg) 
significantly reduced the renal oxalate content and 
other stone forming constituents in both prophylactic 
and curative treatment groups. Renal stone induction 
was significantly aggravated (P <0.001) % LPO of 
kidney tissue in lithiatic rats, which was effectively 
prevented by simultaneous treatment with t-CA in the 
experimental animals. 
 
Effect of t-CA on histological evaluation of kidney 
In histopathological evaluation, we have found 
normal architecture of the kidney in the vehicle 
treatment group (Fig. 5). In contrast to this, extensive 




Fig. 4 — Effect of t-CA on (A) Creatinine; (B) Uric acid from the serum samples; and (C) Oxalate; (D) Calcium; and (E) LPO% from the 
kidney homogenate samples. [Gr. I, vehicle control; Gr. II, lithiatic control (EG); Gr. III, cystone @750 mg/kg; Gr. IV and V, t-CA 
preventive @200 and 400 mg/kg; and Gr. VI & VII, t-CA curative @200 and 400 mg/kg, respectively. Values are expressed as mean ± 
SEM, n = 6, ANOVA followed by Dunnett ’s multiple comparison test, *P <0.05, **P <0.01, ***P <0.001. Comparisons are made 




Fig. 5 — Photomicrographs of the kidney sections. (A) Vehicle control: normal glomerular structure and renal tubules; (B) Urolithic: 
Oxalate renal stone and tubular dilation and renal tubular damage; (C) Cystone 750 mg/kg: Little tubular dilation and normal glomeruli; 
(D) Preventive t-CA 200 mg/kg: Tubular dilation and Bowmen’s capsule space dilated and partial atrophy of glomeruli; (E) Preventive t-
CA 400 mg/kg: Little tubular dilation and normal glomeruli; (F) Curative t-CA 200 mg/kg: Partial atrophy of glomeruli little tubular 
dilation and normal glomeruli; and (G) Curative: t-CA 400 mg/kg (H and E 40X) 
 




structures were found in EG-treated rats. These patho-
logical changes were reversed by cystone (750 mg/kg) 
and t-CA (200 and 400 mg/kg) treatments. 
 
Effect of t-CA on urinary crystal 
In the microscopic examination, after 28 days of 
EG-treatment, urine samples from Gr. I rats showed 
the absence of any crystal, whereas the presence of 
abundant CaC2O4 crystals (needle-shaped) and in 
many instances their aggregates were visible in the 
urine samples of Gr. II rats. In cystone (750 mg/kg)-
treated group, a drastic decrease in several urinary 
crystals was observed. The CaC2O4 crystals observed 
in preventive groups were significantly smaller in size 
as compared to lithiatic-treated rats. Moreover, 
curative groups also exhibited less CaC2O4 crystals. 
Besides, certain CaC2O4 crystals were also found to 
be broken in a few instances (Fig. 6). 
 
Discussion 
The present study demonstrated antiurolithiatic effect 
of oral administration of t-CA on EG-induced 
urolithiasis in experimental rats. There were no signs of 
toxicity during the entire study duration i.e. four weeks 
of the treatment doses. Although calcium channel 
blockers, steroids, NSAIDs, and α1 adrenergic receptor 
antagonists are the primary agents used in the 
therapeutic intervention and management of urolithiasis, 
these treatment regimens have numbers of side effects
25
. 
Therefore, alternative treatments with phytoconstituents 
have become the mainstay of medical therapy. 
 
Diverse animal models are used for induction of 
CaC2O4 crystals in experimental rats. The most 
commonly employed simplest method is to provide EG 
in drinking water. EG is readily absorbed along with the 
intestine, metabolized in the liver to oxalate causing 
hyperoxaluria, and precipitates in the urine as CaC2O4 
as a result of its poor solubility. In particular, CaC2O4 in 
nephron leads to damage of epithelial cells, inducing 
heterogeneous crystal nucleation and causing 
aggregation of crystals
26,27
. Male rats were selected to 
induce urolithiasis because the urinary system of male 
rats resembles that of humans and earlier studies 
reported inhibitory effects of female sex hormones on 
kidney stone formation in experimental animals
18,28,29
.  
Urinary chemistry is one of the important factors in 
determining the type of crystal formed and the nature 
of macromolecules included on the surface of the 
crystals. Hence, the study of the urinary chemistry 
related to the calculi forming minerals may provide a 
good indication of the extent of stone formation. One 
previous study reported that urinary volume was 
decreased in EG-induced urolithic rats
19
. The 
treatment with t-CA increased urine output in 
experimental rats and this may be due to the diuretic 
effect of t-CA which reduces the CaC2O4super 
saturation in the urine and thereby stone formation. 
It is well-known that oxalate plays an important role 
in stone formation and has about a 15-fold greater effect 
than urinary calcium
30,31
. In the present study, urinary 
oxalate levels were increased in EG-induced urolithic 
rats. A reduction in oxalate content in urine samples of t-CA 
treated rats was observed. This could be attributed to the 
inhibitory activity of t-CA treatment on oxalate formation. 
Furthermore, urinary phosphorus excretion was 




Fig. 6 — Polarization micrograph of 24 h morning rat’s bladder urine. (A) Control animals showed no deposition of crystals; (B) Needle-
shaped oxalate crystals depositions were observed in lithiatic control group; (C) Crystals were not observed in cystone (750 mg/kg)-
treated group; (D) Partial crystal deposition showed in preventive lower (200 mg/kg) dose-treated group;. (E) No depositions of crystals 
were observed in preventive higher (400 mg/kg) dose-treated group; and (F & G) Curative lower (200 mg/kg) and higher (400 mg/kg) 
groups  showed absence of crystals, Original magnifications of 40X] 
 




reported that increased urinary phosphorus excretion 
along with oxalate stress seems to provide an environment 
appropriate for stone formation by forming calcium 
phosphate crystals, which epitaxially induces CaC2O4 
deposition
8,18,29
. Treatment of t-CA lowered the 
excretion of phosphorus and reduced the risk of stone 
formation. Moreover, urine samples from urolithic 
group showed increased urinary uric acid excretion. 
Uric acid interferes with CaC2O4 solubility and reduces 
the inhibitory activity of glycosaminoglycans on adherent 
crystals
16
. Treatment with t-CA remarkably lowered the 
uric acid content in urine samples of t-CA treated rats.  
It is well characterized that high urinary calcium 
concentration leads to an increase in urinary saturation 
of calcium salts and reduction in urinary inhibitory 
activity by the way of complex formation with 
negatively charged inhibitors such as citrate
30
. The 
present study showed a marked increase in urinary 
calcium excretion and urinary calcium levels in 
urolithiatic rats. Treatment strategies aimed at reducing 
urinary calcium levels showed reduced stone recurrence 
rates. Interestingly, treatment with t-CA efficiently 
prevented lithogen-induced hypercalciuria thereby 
inhibiting calcium stone formation better than cystone. 
In addition, urinary magnesium levels were 
diminished in EG-induced urolithic rats, whereas 
treatment with t-CA restored the magnesium levels in 
urine and thus, reduced the growth of CaC2O4 crystals. 
These results are in harmony with the previous studies 
which reported that the low magnesium levels may pose 
a threat of stone formation as the supersaturation of 
CaC2O4 is reduced by the magnesium complexes with 
oxalate and thereby reduces the growth and nucleation 
rate of CaC2O4 crystals
8,29
. 
Calcium and oxalate levels were markedly increased 
in the renal tissue of EG-treated rats due to the 
expression of intracellular CaC2O4 crystal. The t-CA 
treatment suppressed the increase in intracellular 
CaC2O4 level as clearly seen in the histopathological 
study. However, these elevations of calcium and oxalate 
were attenuated by treatment with the t-CA and, thereby 
decreased CaC2O4 crystal-induced cell-injury. t-CA 
significantly prevented all these effects of lithogenic 
treatment. Thus, confirming in vivo antiurolithic effect. 
Moreover, renal function was assessed by 
measuring serum creatinine, and uric acid. The 
glomerular filtration rate (GFR) decreases due to the 
obstruction of the urine outflow by stones in 
urolithiasis. Therefore, the waste products particularly 
creatinine, and uric acid accumulate in the blood
32
. In 
the present study, the administration of EG caused 
nephrotoxicity which was characterized by marked 
elevation of serum creatinine and uric acid levels. 
Treatment with t-CA significantly decreased the 
nephrotoxicity indicated by improved GFR and 
thereby decreased the levels of serum creatinine, and 
uric acid. The elevated level of LPO causes renal 
damage by reacting with polyunsaturated fatty acids 
in the cell membrane of the kidney
10,29
. The LPO 
levels were increased in the kidney homogenate of 
EG-treated rats. The t-CA treatment successfully 
prevented an increase in LPO in experimental rats 
confirming its antioxidant potential. 
In the present study, we examined the effect of t-CA 
on urinary pH. It is reported that a decrease in urinary 
pH is associated with increased CaC2O4 production
33
. 
Obtained data showed that urine pH was significantly 
decreased in EG-treated rats and thus, increased CaC2O4 
production. These results are in harmony with previous 
studies
26,29
. The treatment with t-CA increased the 
urinary pH leading to promote secondary nucleation of 
CaC2O4 by precipitation of calcium phosphate and 
confirmed its antiurolithiatic effect.  
Histopathological examination of the kidney sections 
of EG-induced urolithic rats showed polymorphic 
irregular and needle-shaped crystal deposits inside the 
tubules causing tubular dilation along with interstitial 
inflammation, renal tubular damage and cell necrosis. 
Treatment with t-CA restored these changes and also 
prevented the damages to the tubules. Several studies 
have reported that cell damage and cell detachment 
resulted from the basement membrane due to crystal 
formation and released degradation products which 
further promote nucleation of crystals
12,29
. In the present 
study, a microscopic examination of urine exhibited 
CaC2O4 crystal deposition in EG-treated rats. 
Administration of t-CA to EG-exposed rats, prevented 
supersaturation of CaC2O4 as confirmed by fewer 
numbers of crystal deposits in renal tubules. 
 
Conclusion 
The present study, for the first time, shows the 
beneficial effect of t-CA in prevention as well as the 
management of urolithiasis in experimental rats. The 
present study showed that t-CA significantly augmented 
serum creatinine, uric acid as well as urine oxalate, 
calcium, magnesium, and phosphate in EG-induced 
urolithiasis after 28 days. Further, t-CA also protected 
renal tissue damage and reduced the level of CaC2O4. 
Our findings demonstrated antiurolithiatic effect conferred 




by t-CA is mediated through a combination of CaC2O4 
crystal inhibitory, diuretic, antioxidant, and hypermagne-
semia activity. Future study should focus on the possible 
role of t-CA in treatment and prevention of urolithiasis 
using different animal models and clinical set up. 
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